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Multipotent, self-renewing neural stem cells reside in the embryonic mouse telencephalic germinal zone. Using an in vitro
eurosphere assay for neural stem cell proliferation, we demonstrate that FGF-responsive neural stem cells are present as
arly as E8.5 in the anterior neural plate, but EGF-responsive neural stem cells emerge later in development in a temporally
nd spatially specific manner. By separately blocking EGF and FGF2 signaling, we also show that EGF alone and FGF2 alone
an independently elicit neural stem cell proliferation and at relatively high cell densities separate cell nonautonomous
ffects can substantially enhance the mitogen-induced proliferation. At lower cell densities, neural stem cell proliferation
s additive in the presence of EGF and FGF2 combined, revealing two different stem cell populations. However, both
GF-responsive and EGF-responsive neural stem cells retain their self-renewal and multilineage potential, regardless of
rowth factor conditions. These results support a model in which separate, lineage-related EGF- and FGF-responsive neural
tem cells are present in the embryonic telencephalic germinal zone. © 1999 Academic PressKey Words: EGF; FGF2; mouse; neural development; neural stem cells; proliferation; telencephalon.
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cINTRODUCTION
The vertebrate central nervous system emerges from a
layer of cytologically indistinct neuroepithelial cells along
the dorsal midline of the embryo, called the neural plate.
The neural plate subsequently undergoes a series of mor-
phogenetic movements to form a neural tube consisting of
prominent vesicles anteriorly, which represent the anlage
of the forebrain, midbrain, and hindbrain, and a slender
portion posteriorly, which develops into the spinal cord.
Clonal analysis has shown that single cells isolated from
the neural tube along the spinal segment are competent to
give rise to clones containing both dorsal (e.g., sensory
ganglion neurons and presumptive pigment cells) and ven-
tral (e.g., motor neurons and floor plate cells) derivatives,c
v
1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (416) 978-3844. E-mail: v.tropepe@utoronto.ca.
166ndicating that neural precursor cells at an early stage are
ot restricted in their potential to generate different cell
ypes along the dorsoventral axis (Artinger et al., 1995).
ndeed, the generation of diverse cellular phenotypes has
een shown to depend upon signals emanating from sur-
ounding tissues that can regulate phenotypic and posi-
ional specification of neural precursor lineages along the
ostrocaudal and dorsoventral axes (reviewed in Lumsden
nd Krumlauf, 1996; Tanabe and Jessell, 1996). Although
he fate of the progeny of multipotential precursors can be
pecified by extrinsic mechanisms at early stages of neural
evelopment, the regulation of the multipotential precursor
opulation itself at these early stages is poorly understood.
t is not known if, for example, all precursors terminally
ifferentiate along with their progeny throughout the
ourse of neurogenesis. The recent identification of stem
ells in the embryonic and adult mammalian central ner-
ous system (reviewed in Weiss et al., 1996) indicates that
0012-1606/99 $30.00
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167Growth Factor-Dependent Neural Stem Cell Proliferationnot all lineage precursors differentiate. Therefore, the regu-
lation of neural stem cell proliferation may be required for
the initial events leading to the elaboration of neural tissue
and the maintenance of discrete regions of neurogenesis in
the adult brain.
Evidence from in vivo lineage analyses and in vitro cell
ulture experiments revealed that the rodent telencephalic
erminal zone (GZ) at embryonic day (E) 14 is composed of
heterogeneous population of multipotential and commit-
ed precursor cells (Gage et al., 1995; Weiss et al., 1996;
cKay, 1997). Neural stem cells, exhibiting the fundamen-
al stem cell properties of multipotentiality and self-
enewal (Potten and Loeffler, 1990), have been shown to
ake up a relatively small percentage of this heterogeneous
14 GZ population (Temple, 1989; Reynolds et al., 1992;
escovi et al., 1993). In the adult forebrain, neural stem
ells are present as a relatively quiescent subpopulation in
he subependyma, a remnant of the embryonic GZ (Reyn-
lds and Weiss, 1992; Morshead et al., 1994; Craig et al.,
996; Gritti et al., 1996), and this population persists into
enescence (Tropepe et al., 1997).
Epidermal growth factor (EGF) and fibroblast growth
actor-2 (FGF2) have been shown to mediate cell prolifera-
ion in the embryonic retina (Anchan et al., 1991; Lillien
nd Cepko, 1992), telencephalon (Gensburger et al., 1987;
rago et al., 1991; Kilpatrick and Bartlett, 1993), hippocam-
us (Ray et al., 1993), mesencephalon (Murphy et al., 1990;
Santa-Olalla and Covarrubias, 1995), and spinal cord (Ray
and Gage, 1994). Furthermore, EGF and FGF2 are critical for
the proliferation of neural stem cells isolated from the
embryonic and adult forebrain GZ (Reynolds et al., 1992;
Reynolds and Weiss, 1992; Vescovi et al., 1993; Gritti et al.,
1996), as well as the embryonic and adult spinal cord (Weiss
et al., 1996; Kalyani et al., 1997). FGF2 is believed to act
primarily through FGF-receptor-1 (FGFR1) (Johnson and
Williams, 1993), and both receptor binding affinity and
growth factor-mediated mitogenicity in many cell types,
including neuroepithelial cells, are dependent on heparin
(Ornitz and Leder, 1992; Roghani et al., 1994; Brickman et
al., 1995). In the rat telencephalon, FGFR1 is expressed as
early as E8.5–E9.5 and this expression is relatively confined
to the ventricular zone during later stages of development
(Orr-Urtreger et al., 1991; Wanaka et al., 1991), while peak
expression of FGF2 occurs at midneurogenesis in predomi-
nantly postmitotic cells (Weise et al., 1993). Targeted null
mutations of FGFR1 cause defects in cell proliferation and
mesoderm patterning and embryos die between E7.5 and
E9.5 (Deng et al., 1994; Yamaguchi et al., 1994; Ciruna et
al., 1997). Thus, FGF-dependent cellular proliferation has a
prominent and ubiquitous role during embryogenesis. The
in vitro evidence for FGF-dependent proliferation of neural
precursor cells and the early expression of FGFR1 in the
telencephalon indicates that neural precursor cell prolifera-
tion is predominantly regulated by FGFs. Low levels of
transforming growth factor-a (TGFa) and the EGF-receptor
(EGFR) are similarly present at relatively early stages of
telencephalic development in mostly ventral regions, with
Copyright © 1999 by Academic Press. All rightan increase in intensity and dorsal distribution at later
embryonic stages (Eagleson et al., 1996; Kornblum et al.,
1997). Both EGF and TGFa bind preferentially to the EGFR
Massague, 1983; Marquardt et al., 1984), but TGFa is
thought to be the predominant endogenous ligand in the
rodent brain (Kornblum et al., 1997). Although there is in
vitro evidence for EGF-dependent proliferation of neural
precursor cells, targeted disruption of the EGFR has no
apparent neural phenotype at early stages of development,
but does cause forebrain cortical dysgenesis at late embry-
onic and postnatal ages with evidence of an attenuated
forebrain, cortical cell death, and hippocampal ectopias
(Threadgill et al., 1995; Sibilia and Wagner, 1995; Sibilia et
al., 1998). Depending on the background genetic strain, the
EGFR(2/2) mutation can cause implantation defects, while
some mice can survive for several weeks postnatally. Both
EGF and FGF2 can elicit the in vitro proliferation of neural
stem cells isolated from the embryonic GZ, but evidence
from the null receptor mutations suggests that there may be
differential in vivo influences of these mitogens on telen-
cephalic neural stem cell proliferation at different stages of
embryonic development.
To determine if EGF and FGF2 have differential roles in
neural stem cell proliferation (and indeed act on different
cells) we analyzed the EGF- and FGF-responsiveness of
neural stem cells from early stages of neural develop-
ment, and tested whether there were quantitative and
qualitative differences between the two mitogenic sig-
nals. In serum-free conditions neural stem cells prolifer-
ate in the presence of FGF2 as early as E8.5, but respond
to EGF only at later stages of embryonic development.
Neural stem cells independently proliferate in response
to EGF and FGF2, and at low cell densities the EGF- and
FGF2-induced proliferation of stem cells is additive.
FGF2 signaling via FGFR1 is critical for proliferation of
FGF2-responsive neural stem cells isolated from the E8.5
anterior neural plate. EGF signaling through the EGFR is
critical for the proliferation of EGF-responsive neural
stem cells, but not FGF2-responsive neural stem cells,
isolated from the E14.5 telencephalic GZ. Furthermore,
in the absence of a functional FGFR1, the expansion of
the FGF2-responsive neural stem cell population, as well
as the emergence of EGF-responsive neural stem cells, is
severely diminished at E14.5. The distinct proliferative
responses to EGF and FGF2 reveal a heterogeneity among
the neural stem cell population itself. Furthermore, our
results suggest that the EGF-responsive stem cells that
are present in the E14.5 GZ are the lineage descendents of
FGF-responsive stem cells that are present as early as
E8.5. In addition, the greater than proportional increase
in the number of embryonic neural stem cells proliferat-
ing in high density cultures demonstrates that the prolif-
eration of neural stem cells can be actively regulated by
additional cellular interactions that were shown to be
separate of both EGF and FGF2 signaling.
s of reproduction in any form reserved.
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168 Tropepe et al.MATERIALS AND METHODS
Isolation of neuroepithelial cells from embryonic day 8.5 em-
bryos. Pregnant CD1 mice (Charles River) at the specified gesta-
tional age of 8.5 days (E8.5) were killed via cervical dislocation and
the uteri were aseptically removed and transferred to petri dishes
containing sterile Dulbecco’s phosphate-buffered saline (PBS;
GIBCO) with 30% glucose (Sigma) and 2% penicillin/streptomycin
(5000 IU; GIBCO). Each decidua from the uterine sac was dissected
out and transferred to a new sterile petri dish containing PBS in
order to rinse away excess blood. Deciduae were then transferred to
a chemically defined serum-free media (Reynolds et al., 1992)
composed of a 1:1 mixture of Dulbecco’s modified Eagle’s medium
(DMEM; GIBCO) and F-12 nutrient (GIBCO) including 0.6% glu-
cose (Sigma), 2 mM glutamine (GIBCO), 3 mM sodium bicarbonate
(Sigma), and 5 mM HEPES buffer (Sigma). A defined hormone and
salt mixture (Sigma) that included insulin (25 mg/ml), transferrin
(100 mg/ml), progesterone (20 nM), putrescine (60 mM), and sele-
nium chloride (30 nM) was used instead of serum. All subsequent
dissection procedures were adapted from Drago et al. (1991). Under
a dissecting microscope (Zeiss), sterile, fine forceps were used to
make a single superficial incision through the narrow end of the
decidual wall. The amniotic sac was gently removed and trans-
ferred to a new petri dish containing fresh media. Embryos were
removed from the amniotic sac and the head primordia were
dissected using fine forceps and microprobe by excising rostral to
the first branchial arch. Using a sterile, fire-polished Pasteur
pipette head primordia were transferred to media containing 0.1%
(w/v) trypsin (Sigma) and 0.001% (v/v) deoxyribonuclease I (10
mg/ml stock DNase I; Boehringer-Mannheim) and incubated at 4°C
for approximately 15 min. After enzymatic dissociation, head
primordia were washed in PBS and subsequently transferred to
media containing 0.7 mg/ml trypsin inhibitor (Boehringer-
Mannheim). Anterior neural plate tissue was gently teased away
from surrounding head mesenchyme and overlying epidermal ec-
toderm. The neuroepithelium was washed in Ca21-Mg21-free
Hank’s buffer (GIBCO) to remove loosely adherent cells. Each
anterior neuroepithelium was transferred to serum-free culture
media containing either 10 ng/ml FGF-2 (human recombinant;
Upstate Biotech) and 2 mg/ml heparin (Upstate Biotech), or 20
g/ml EGF (mouse submaxillary; Upstate Biotech), mechanically
issociated into single cells and plated in uncoated 24-well plates
0.5 ml/well; Nunclon). Each dissection yielded an average of 5000
iable cells/well assessed using trypan blue exclusion (0.4%;
IBCO). Due to the limited amount of viable cells recovered from
hese small tissue samples, one E8.5 anterior neural plate dissec-
ion per well was plated. The average cell plating density was
stimated at 10 cells/ml (from n 5 6 embryos).
Isolation of ventricular zone cells from embryonic days 13.5–
15.5 embryos and postnatal day 3 mice. Pregnant CD1 mice of
gestational age 13.5, 14.5, or 15.5 days (E13.5, E14.5, E15.5) were
killed via cervical dislocation and embryos were removed as
described above. Postnatal day 3 mice were anesthetized at 4°C and
decapitated. In PBS (as above) the brains of each embryo and
postnatal mouse was removed and overlying meninges and blood
vessels were removed. Dissected cortical or striatal GZ tissue was
transferred to serum-free media and mechanically dissociated into
a cell suspension with a fire-polished Pasteur pipette. Cell viability
was assessed using trypan blue (as above). Cells were plated in
96-well (0.2 ml/well), 24-well (0.5 ml/well), or 6-well (2 ml/well)
uncoated plates (Nunclon) depending on the experimental condi-
tions in serum-free media containing growth factors (as above). In
s
s
Copyright © 1999 by Academic Press. All rightorder to assess self-renewal, E8.5, E13.5–15.5, and P3 primary
neurospheres (selecting mainly floating neurospheres after 6–7
days in vitro) were passaged by mechanically dissociating a single
neurosphere in 0.2 ml of serum-free media, in identical growth
factor conditions as the primary culture, and plated in uncoated
96-well (0.2 ml/well) plates (Nunclon). Passagibility was assessed
by identifying new neurospheres after a further 6–7 days in vitro.
For E14.5 and P3 dose–response experiments, the molarity values
for each of the concentration points chosen are: (1) for FGF2, 0.05
ng/ml 5 3.5 3 10212 M; 0.2 ng/ml 5 1.4 3 10211 M; 0.6 ng/ml 5
.8 3 10211 M; 2 ng/ml 5 1.2 3 10210 M; 10 ng/ml 5 5.7 3 10210 M;
20 ng/ml 5 1.14 3 1029 M; 40 ng/ml 5 2.28 3 1029 M; 80 ng/ml 5
4.57 3 1029 M; and (2) for EGF, 0.05 ng/ml 5 1.0 3 10211 M; 0.2
g/ml 5 4.0 3 10211 M; 0.6 ng/ml 5 1.1 3 10210 M; 2 ng/ml 5 3.3 3
0210 M; 10 ng/ml 5 1.64 3 1029 M; 20 ng/ml 5 3.28 3 1029 M; 40
ng/ml 5 6.56 3 1029 M; 80 ng/ml 5 1.31 3 1028 M.
For the growth factor dose-dependent clonal analyses, E14.5 GZ
tissue was isolated as above and cells were plated at 4 3 105 cells
per 94-mm Greiner hybridoma tissue culture dish (Fedoroff et al.,
1997), which is subdivided into approximately 700 microwells,
0.04 cm2 each (Greiner Labortechnik, Bellco Glass, Inc., Vineland,
J). Using this procedure, microwells containing 0 cells, 1–3 cells,
r greater than 3 cells per well were scored after approximately 24 h
randomly assorted cells), and only the wells containing 1–3 cells
ere followed for the 7-day culture period for the presence of
eurospheres in three separate growth factor concentration condi-
ions (0.6, 20, 80 ng/ml) for both EGF and FGF2. Single neuro-
pheres generated in all conditions were either passaged to assay for
he generation of secondary and tertiary neurospheres (as above) or
lated to assess their differentiation potential (see below).
Generation of FGFR1 tetraploid and diploid chimeras. The
eneration of FGFR1 tetraploid and diploid chimeric mice was
xactly as previously described by Ciruna et al. (1997). Briefly, ES
ell lines that were homozygous for the fgfr1Dtmk allele, previously
identified as a functional null mutation (Yamaguchi et al., 1994),
and marked with a ubiquitously expressed lacZ marker (Friedrich
and Soriano, 1991) were used for generating chimeras (Ciruna et al.,
1997). These ES cells (as well as fgfr1Dtmk/1 control ES cells) were
ggregated with two tetraploid CD1 embryos, produced by electro-
usion of embryos at the two cell stage, and aggregates were
ransferred to the uteri of CD1 foster mothers. Embryos were
ubsequently isolated at 8.5 days of gestation and anterior neural
late tissue was dissected, dissociated, and plated in serum-free
edia (as above) in order to assay for neurosphere formation.
iploid chimeric embryos were generated by aggregating 8–10 cell
orulae of fgfr1Dtmk/fgfr1Dtmk ES cells (or fgfr1Dtmk/1 control ES cells)
ith CD1 8-cell embryos. Aggregates were transferred into the
teri of CD1 foster mothers, and chimeric embryos were isolated at
14.5. Striatal GZ tissue was dissected from one hemisphere (the
ther was used for X-gal staining—see below), dissociated and
lated in serum-free media (as above), and the number of neuro-
pheres generated in the presence of either EGF or FGF2 was
ssayed after 7 days. Tetraploid and diploid chimeric animals will
e refered to as ROSA26-FGFR1(2/2) or ROSA26-FGFR1(1/2), mu-
ant, and control, respectively, throughout.
Whole mount b-Gal staining for E14.5 chimeric embryonic
brains and neurospheres. E14.5 embryonic brain hemispheres (or
neurospheres) generated from the E14.5 diploid chimeras were
rinsed in 100 mM sodium phosphate buffer (pH 7.4) and then fixed
in 0.2% gluteraldehyde, 2 mM MgCl2, 5 mM EDTA, and 100 mM
odium phosphate (pH 7.3) at room temperature for 5 min (neuro-
pheres) or 15 min (brains). Single brain hemispheres (or neuro-
s of reproduction in any form reserved.
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169Growth Factor-Dependent Neural Stem Cell Proliferationspheres) were then washed (33) in wash buffer containing 0.02%
NP-40, 0.01% deoxycholate, 2 mM MgCl2, and 100 mM sodium
phosphate (pH 7.3) for 5–15 min each. Brain hemispheres (or
neurospheres) were stained in 1 mg/ml X-gal, 5 mM K3Fe(CN)6, 5
mM K4Fe(CN)6, 0.02% NP-40, 0.01% deoxycholate, 2 mM MgCl2,
and 100 mM sodium phosphate buffer (pH 7.3) at 37°C overnight.
Single brain hemispheres (or neurospheres) were then rinsed with
wash buffer and stored at 4°C. For forebrain sections, brain hemi-
spheres were postfixed overnight in 4% paraformaldehyde at 4°C,
subsequently cryoprotected with 20% sucrose, cryosectioned at 14
mm, and then counterstained with 0.5% safranin (stains the entire
cell light red). In order to estimate the percent chimerism in the
striatal germinal zone region, four to six sections (obtained from
every 10th serial section through the forebrain) were used to
determine the proportion of blue (X-gal-positive) cells. Cell counts
(a total of approximately 500 cells counted in any one section) were
obtained using a phase-contrast Nikon microscope (203 objective).
Genotyping mouse embryos from EGFR heterozygote matings.
Targeted disruption of the mouse EGFR was carried out as previ-
ously described (Sibilia and Wagner, 1995). A total of 12 pregnant
female mice, from EGFR heterozygote matings (129/B6xB6) were
analyzed in order to obtain an adequate number of mutant em-
bryos. DNA was prepared from yolk sacs or tails and genotyped by
PCR and primers used for amplification of wild-type and mutant
alleles was as previously described (Sibilia and Wagner, 1995).
Dose–response analysis for EGFR-inhibitor and Anti-FGF2 an-
tibody effects on neurosphere formation. The generation of pri-
mary neurospheres isolated from the E14.5 GZ (1 3 105 cells in 2
l) in the presence of EGF (20 ng/ml) and various concentrations of
he EGFR inhibitor (referred to as PD) (Park Davis, PD 153035; Fry
t al., 1994) was determined. At plating densities of 50 cells/ml and
5 6 embryos for each group, the number of neurospheres (mean
ercentage of control 6 SEM) generated were as follows: Dimethyl
sulphoxide (DMSO) control 5 100 6 9.0; 0.0036 mM PD 5 51.5 6
.5; 0.032 mM PD 5 3.24 6 0.9; 0.16 mM PD 5 2.37 6 0.8; 0.8 mM
D 5 1.45 6 0.4. Since there was some evidence for reduced
iability at the 0.8 mM concentration, we used 0.16 mM for
ubsequent analyses, which resulted in similar viability to the
MSO control. The same analysis was performed for the anti-FGF2
ntibody (IgG, Upstate Biotech) in the presence of FGF2 (10 ng/ml)
nd heparin (2 mg/ml) at plating densities of 50 cells/ml and n 5 6
mbryos for each group. A nonspecific control antibody (conAb) of
imilar species (mouse) and isotype (anti-MAP2 monoclonal IgG)
as also used to compare to the PBS control. The percentages of
eurospheres (mean percent of PBS control 6 SEM) generated were
s follows: PBS control 5 100 6 5.0; 0.125 mg/ml conAb 5 100.5 6
.2; 1.25 mg/ml conAb 5 96.6 6 5.5; 0.125 mg/ml anti-FGF2 5
12.4 6 2.14; 1.25 mg/ml antiFGF2 5 1.14 6 0.6; 12.5 mg/ml
nti-FGF2 5 0.21 6 0.1. There were no significant differences
etween the PBS control and the conAb conditions. There was
ome evidence for compromised viability at the 12.5 mg/ml con-
centration of the anti-FGF2. Therefore, we used 1.25 mg/ml anti-
GF2 for subsequent analyses, which resulted in similar viability of
ells when compared to the PBS control and the 1.25 mg/ml conAb.
Cryosectioning neurospheres. Using a Pasteur pipette, neuro-
pheres cultured for 6 or 7 days in vitro were transferred and
ashed (23) in 10 mM phosphate-buffered saline (PBS, pH 7.2) for
few seconds for each wash. Neurospheres were then transferred to
% paraformaldehyde containing 0.4% picric acid in 0.16 M
hosphate buffer (pH 6.9) (Zamboni and de Martino, 1967) and fixed
or 1 h at room temperature. Neurospheres were washed (33) in 10
M PBS for 5 min each prior to being resuspended in 10% sucrose
Copyright © 1999 by Academic Press. All rightin 10 mM PBS) overnight at 4°C. The following day, neurospheres
ere placed in tissue freezing media (Tissue Tek) in order to quick
reeze to 250°C. Using a cryostat, serial 14-mm sections were taken
nd collected on gelatin-coated slides. Slides were stored at 270°C.
Immunocytochemistry on sectioned whole neurospheres.
elatin-coated slides containing neurosphere sections were al-
owed to rehydrate with PBS for 10 min. For nestin immunocyto-
hemistry, a rabbit polyclonal antiserum (a gift from Dr. R. McKay)
Tohyama et al., 1992) was diluted to 1:1000 (in PBS 1 Triton-X)
nd sections were incubated overnight at 4°C. Sections were then
ashed (33) in 10 mM PBS (5 min each) and subsequently incu-
ated with secondary anti-rabbit FITC-conjugated antibody (1:200;
igma) for 1 h at room temperature. Sections were washed (33) (5
in each) and then cover-slipped with Fluor-mount mounting
edium. Fluorescence was detected on a Nikon microscope. For
GFR (Sugiyama et al., 1989) and FGFR1 (Werner et al., 1993)
mmunocytochemistry, neurosphere sections were rehydrated
ith PBS for 10 min and incubated overnight at 4°C in sheep
nti-mouse EGF-receptor (1:100; Biodesign International) in PBS
ontaining 0.3% Triton-X and 10% donkey serum. Sections were
insed with PBS for 10 min and then incubated in Cy3 donkey
nti-sheep secondary antibody (1:300; Jackson ImmunoResearch)
n PBS containing 0.3% Triton-X and 10% donkey serum. After
insing in PBS for 10 min, sections were incubated in rabbit
nti-mouse FGF-receptor-1 (1:250; a gift from Dr. L. Williams) in
BS containing 0.3% Triton-X and 10% donkey serum. Sections
ere again rinsed with PBS for 10 min and subsequently incubated
n biotinylated donkey anti-rabbit (1:200; Jackson ImmunoRe-
earch) for 1 h at 37°C, followed by rinsing in PBS for 10 min, and
nally incubated in streptavidin Cy2 (1:1000; Jackson ImmunoRe-
earch) in PBS only for 1 h at 37°C. Sections were rinsed (23) for 10
in each and cover-slipped in Fluor-mount. Fluorescence was
etected on a Nikon Microphot microscope.
Immunocytochemistry on differentiated neurospheres. Six
ays after primary culture, single neurospheres were transferred
sing a Pasteur pipette onto glass coverslips coated with MATRI-
EL basement membrane matrix (15.1 mg/ml stock solution
iluted 1:50 in serum-free media; Becton-Dickinson) in individual
ells of a 24-well culture plate (Nunclon) (0.5 ml/well) in serum-
ree media containing various growth factor concentrations, or in
edia containing 10% FBS and no extra growth factor. Media was
ot changed for the rest of the culture period. Coverslips were
rocessed 6–7 days later using immunocytochemistry. Coverslips
ere fixed in 4% paraformaldehyde (in PBS, pH 7.2) for 30 min at
oom temperature followed by 3 (5 min each) washes in PBS (pH
.2). Cells were then permeabilized for 5 min in PBS containing
.3% Triton-X, rinsed for 5 min (23) in PBS and blocked for 1 h in
PBS containing 10% normal goat serum (NGS). After blocking,
coverslips were incubated in anti-MAP-2 mouse monoclonal (IgG)
(1:1000; Boehringer-Mannheim) and anti-GFAP rabbit polyclonal
(IgG) (1:400; Chemicon) antibodies diluted in PBS containing 10%
NGS for 2 h at 37°C. Coverslips were then rinsed in PBS three
times (5 min each) and subsequently incubated in FITC goat
anti-rabbit (1:200; Jackson ImmunoResearch) and TRITC goat
anti-mouse (1:200; Jackson ImmunoResearch) secondary antibod-
ies at 37°C for 30 min. Coverslips were rinsed three times (5 min
each) in PBS. Separate coverslips (from similar culture conditions)
were used for oligodendrocyte staining. Coverslips were incubated
in anti-O4 mouse monoclonal (IgM) antibody (1:40; Boehringer-
Mannheim) in PBS containing 10% NGS at 4°C overnight. The
next day, coverslips were rinsed three times (5 min each) and
subsequently incubated in DTAF goat anti-mouse-IgM (1:200;
s of reproduction in any form reserved.
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170 Tropepe et al.Jackson ImmunoResearch) secondary antibody in PBS containing
10% NGS at 37°C for 30 min. After rinsing three times (5 min
each), all coverslips were incubated in Hoechst 33258 nuclear stain
(0.015 mg/ml stock solution diluted to 0.001 mg/ml; Boehringer-
Mannheim) for 20 min at room temperature.
For secondary neurospheres generated from primary clonal mi-
crowell cultures in various concentrations of EGF or FGF2 (see
above), triple-labeling was performed. The procedure was identical
to the above described double-labeling procedure except that the
secondary antibody used to detect GFAP-positive cells was an
AMCA goat anti-rabbit antibody (1:200 dilution; Jackson Immu-
noResearch) and counterstaining with Hoechst was not performed.
All coverslips were rinsed for 5 min in PBS (33) and mounted in
Fluormount. Fluorescence was visualized using a Nikon Microphot
microscope. Secondary antibody-only control coverslips were pro-
cessed simultaneously using the identical protocol except dilution
solutions were devoid of primary antibodies. All secondary controls
were negative for staining.
Limiting dilution analysis. Limiting dilution analysis was per-
formed according to Bellows and Aubin (1989). Cells isolated from
the E14.5 striatal germinal zone were plated in 96-well microwell
plates containing either EGF (20 ng/ml), FGF2 (10 ng/ml) 1
eparin, or EGF 1 FGF2 1 heparin. Cell numbers were adjusted to
give a starting concentration of 4000 cells/ml from which serial
dilutions were made. Final cell dilutions ranged from 500 cells per
well to 1 cell per well in 0.2-ml aliquots. Cultures were left
undisturbed for approximately 7 days after which time the fraction
of wells not containing neurospheres for each cell plating density
was calculated and those points were plotted against the number of
cells plated per well. The number of cells required to form one
neurosphere, which reflected the proportion of neural stem cells in
the entire population, was then determined from the point at
which the line crossed the 0.37 level. That is, F0 5 e2x, where F0 is
the fraction of wells without neurospheres and x is the mean
number of cells per well. Based upon a Poisson distribution of cells,
F0 5 0.37 corresponds to the dilution at which there is one neural
stem cell per well.
RESULTS
Neural Stem Cells Differentially Proliferate in
Response to EGF and FGF Depending on
Embryonic Age and Telencephalic Region
Given that neural stem cells are the lineage precursors to
neuronal and glial progenitors, they are likely to be present
in the GZ prior to E14 since postmitotic neurons are
present in the mouse forebrain as early as E11 (Smart and
Smart, 1982). Neural stem cells isolated from the E14
striatal GZ have been shown to proliferate in response to
EGF and FGF2 in serum-free culture conditions to give rise
to clonal aggregates of undifferentiated neural precursors,
called neurospheres (Reynolds et al., 1992; Vescovi et al.,
993). E14 neural stem cells have the classical properties of
elf-renewal and multipotentiality (Reynolds and Weiss,
996). To determine if neural stem cells are present at very
arly stages of development, prior to neural tube formation,
nterior neural plate tissue was isolated from E8.5 embryos
nd plated in the presence of EGF or FGF2. Neurospheres
ere generated from E8.5 anterior neural plate tissue in the
Copyright © 1999 by Academic Press. All rightresence of FGF2 alone, but not in EGF alone (Fig. 1A).
ncreasing the concentration of EGF from 20 to 80 ng/ml
id not cause neurospheres to form; whereas, increasing the
oncentration of FGF2 to 80 ng/ml did not significantly
ncrease the number of neurospheres generated compared to
0 ng/ml of FGF2 (data not shown). Single FGF2-generated
rimary neurospheres from E8.5 anterior neural plate were
apable of generating secondary neurospheres when pas-
aged in either EGF (3.86 6 1.0 secondary neurospheres
enerated from a single primary neurosphere, n 5 7) or
FGF2 (5.42 6 1.3 secondary neurospheres generated from a
single primary neurosphere, n 5 7). This suggests that the
cells isolated at E8.5 are not only capable of self-renewal in
FGF2, but also that single FGF-responsive cells can give rise
to stem cells capable of generating neurospheres in EGF.
Based on our estimate of the numbers of viable cells
isolated and plated from a single embryonic anterior neural
plate dissection (;5000; see Materials and Methods), the
estimated frequency of neural stem cells that proliferate in
the presence of FGF2 at this early developmental age was
approximately 0.3% in the anterior neural plate. Thus,
self-renewing neural stem cells are present in the develop-
ing nervous system as early as E8.5 and are competent to
proliferate in response to FGF2, but not EGF. Furthermore,
FGF-responsive stem cells at E8.5 appear to be the lineage
precursors to EGF-responsive stem cells.
Since neural stem cells are not responsive to EGF at E8.5,
but do proliferate in response to EGF at E14.5, we asked if
the growth factor responsiveness of neural stem cells was
dependent on the developmental stage and spatial localiza-
tion within the telencephalic GZ (i.e., the cortical and
striatal germinal zones, the major E14.5 telencephalic de-
rivatives of the anterior neural plate germinal zone). Neural
tissue was isolated from the striatal GZ and cortical GZ at
E13.5, E14.5, and E15.5. At E13.5 the numbers of neuro-
spheres generated per numbers of cells plated from both the
cortical GZ and striatal GZ in the presence of EGF was
significantly less than the numbers of neurospheres gener-
ated in the presence of FGF2 (Fig. 1B). By E14.5, more
neurospheres were generated per numbers of cells plated in
FGF2 compared to EGF from the striatal GZ; however,
significantly fewer EGF-generated neurospheres than FGF2-
generated neurospheres were isolated from E14.5 cortical
GZ. At E15.5, the numbers of neurospheres generated from
both the cortical GZ and striatal GZ were not significantly
different in the presence of either EGF or FGF2 (Fig. 1B).
Therefore, FGF2-responsive neural stem cells are present
before EGF-responsive neural stem cells in both the striatal
and cortical GZs. By E15.5, however, similar numbers of
EGF- and FGF2-responsive neural stem cells are found
within the striatal GZ or within the cortical GZ.
To determine if the single cells giving rise to the neuro-
spheres were in fact multipotential, individual neuro-
spheres were plated down on coverslips and cultured in the
presence of 10% fetal bovine serum (FBS), or in similar
concentrations of EGF or FGF2 as the primary or secondary
neurosphere cultures without FBS (see below) to allow for
s of reproduction in any form reserved.
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171Growth Factor-Dependent Neural Stem Cell Proliferationdifferentiation. After 6 days in vitro, the cultures were
rocessed for immunocytochemistry to detect neuronal and
lial cell types. Under these conditions, single neurospheres
enerated from each of the E8.5 anterior neural plate and
he E14.5 striatal GZ and cortical GZ each contained
eurons (MAP21), astrocytes (GFAP1), and oligodendro-
cytes (O41) (Fig. 1C). These findings indicate that multipo-
tential neural stem cells are present at the earliest stages of
development, and that FGF-dependent proliferation of neu-
FIG. 1. Neural stem cells are differentially responsive to EGF an
Neural stem cells isolated from the E8.5 anterior neural plate prolif
10 ng/ml; n 5 22 embryos) and heparin, but not in the presence of
10 cells/ml (0.5 ml/well) from at least three separate experiments.
(10 ng/ml; n 5 6 embryos) and heparin from striatal and cortical G
density of 10 cells/ml (0.2 ml/well). Note that the Y axes change w
Representative triple-immunocytochemical labeling for neurons (a
derived from a single E14.5 neurosphere cultured for 6–7 days in se
in media containing 10% FBS. All three cell types are present in n
E13.5–E15.5 telencephalic GZ. Scale bar, 25 mm.ral stem cells occurs earlier in embryogenesis than the
EGF-dependent proliferation of these cells.
t
p
Copyright © 1999 by Academic Press. All rightOverlapping Expression of EGF-Receptor, FGF-
Receptors, and Nestin in the Cells of Neural Stem
Cell-Derived Neurospheres
Since both the EGF-receptor (EGFR) and the FGF-
receptor-1 (FGFR1) are expressed in the E14 forebrain ger-
minal zone it was of interest to determine if each of the
EGF-responsive and FGF-responsive neurospheres ex-
pressed a single receptor or both receptors. There is indirect
evidence that the in vivo distributions of these two recep-
F2 at different embryonic ages of telencephalic development. (A)
to form neurospheres after 7 days in vitro in the presence of FGF2
(20 ng/ml; n 5 20 embryos). Cells plated at an average density of
eurospheres generated in EGF (20 ng/ml; n 5 6 embryos) or FGF2
lls isolated at E13.5, E14.5, and E15.5 and plated in duplicate at a
ge. *Indicates P , 0.05 compared to immediately adjacent bar. (C)
AP21), astrocytes (anti-GFAP1), and oligodendrocytes (anti-O41)
free media and then allowed to differentiate for a further 6–7 days
pheres generated from either the E8.5 anterior neural plate or thed FG
erate
EGF
(B) N
Z ce
ith a
nti-M
rum-
eurosors in the E14.5 germinal zone are not completely overlap-
ing. Eagleson et al. (1996) reported that the greatest inten-
s of reproduction in any form reserved.
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172 Tropepe et al.sity of EGFR immunostaining was observed in the
subventricular zone, while others report intense FGFR1
mRNA levels in the ventricular zone (Wanaka et al., 1991),
suggesting that subpopulations of neural precursors may
express only one type of receptor in slightly different
regions of the forebrain germinal zone. In order to deter-
mine if neural stem cells isolated in EGF or FGF2 expressed
either EGFR, FGFR1, or both, neurospheres were generated
in the presence of either EGF or FGF2. After 6 days in
culture, 14-mm cryosections from single neurospheres were
btained and processed for EGFR, FGFR1, and nestin im-
unocytochemistry.
Single neurospheres from a primary culture can be disso-
iated into single cells, whereupon a small percentage of
hese cells generate new neurospheres (Reynolds and Weiss,
996). Thus, only a small percentage of all of the cells
ithin a neurosphere are neural stem cells, thought to be
FIG. 2. Expression of nestin, EGFR, and FGFR1 in neural stem ce
cultured for 6 days in vitro in the presence of either EGF (20 ng/ml)
at 14 mm and immunocytochemically labeled for EGFR (red) (A), F
ajority of cells are nestin1 and double-label for EGFR and FGFR1
f arrowed region in (D). Arrows point to cells expressing mostly E
mm.erived from the symmetrical division of the initial stem
ell, and the remaining cells are neural progenitor cells.
f
F
Copyright © 1999 by Academic Press. All rightince the intermediate filament protein nestin is expressed
n all neural precursor cells (Lendahl et al., 1990), we
easoned that a qualitative analysis of the expression pat-
ern of the two growth factor receptors and nestin within a
ingle neurosphere generated in either EGF or FGF2 would
e useful in identifying any precursor cells, some of which
re stem cells, within a neurosphere that express only one
r both growth factor receptors. The analysis revealed that
irtually all of the cells within a single neurosphere express
estin regardless of the growth factor conditions used to
enerate the neurospheres (Fig. 2D). These results are con-
istent with previous reports that virtually all cells within
eurospheres generated from the adult subependyma ex-
ress nestin (Gritti et al., 1996). The expressions of the
GFR (Fig. 2A) and of FGFRs (Fig. 2B) also were ubiquitous
hroughout the cells in the neurospheres, similar to nestin.
ouble-labeling revealed that virtually all cells derived
rived neurospheres. Neurospheres generated from E14.5 GZ tissue
F2 (10 ng/ml) and heparin (2 mg/ml) were fixed and cryosectioned
1 (green) (B), EGFR1FGFR1 (yellow) (C), and nestin (D). The vast
rdless of the primary growth factor conditions. (E) Magnified view
(red) or mostly FGFR1 (green). Scale bars A, B, C, D, 200 mm; E, 50ll-de
or FG
GFR
regarom a neural stem cell clone (isolated in either EGF or
GF2) express both EGFR and FGFR (Fig. 2C). However,
s of reproduction in any form reserved.
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173Growth Factor-Dependent Neural Stem Cell Proliferationthere were varying levels of expression of these receptors in
the individual cells, and there were a few single cells within
each neurosphere which express mostly EGFR or mostly
FGFR (Fig. 2E). The presence of these few cells dominated
by the expression of one receptor suggests the possibility
that there may be a maintenance of a small number of
differentially sensitive neural stem cells that remain undif-
ferentiated and capable of self-renewal. Given that cells in
the neurospheres generated in either EGF or FGF2 express
both growth factor receptors and that neurospheres can be
passaged in either EGF or FGF2 regardless of initial growth
factor conditions (data not shown), then we conclude that
the stem cell initially responsive to either EGF or FGF2 can
subsequently generate more stem cells that are responsive
to both mitogens.
The Proliferative Response of Neural Stem Cells to
Different Concentrations of EGF and FGF2 Is
Dependent upon Cell Density
Although a single neural stem cell can proliferate to form
a neurosphere in vitro, the factors affecting the proliferative
behavior of neural stem cells among a population of precur-
sors, a situation more akin to the in vivo GZ environment,
is poorly understood. We examined whether the prolifera-
tive response of neural stem cells in the presence of varying
concentrations (see Materials and Methods for conversions
from molarity to ng/ml) of EGF and FGF2 was cell density-
dependent by assaying the number of neurospheres gener-
ated from a primary E14.5 GZ dissection. A dose–response
analysis revealed that at high cell densities (50 cells/ml) and
ow mitogen concentrations (0.05–2 ng/ml), EGF was an
rder of magnitude more effective than FGF2 in generating
eurospheres, but at higher concentrations (10–80 ng/ml)
oth EGF and FGF2 elicited the proliferation of the same
aximal number of neural stem cells to form neurospheres
Fig. 3A). However, at relatively lower densities (10 cells/ml)
nd low mitogen concentrations, FGF2 was more effective
han EGF in generating neurospheres and FGF2 generated a
igher maximal number of neurospheres at higher concen-
rations (Fig. 3B). Furthermore, the maximal numbers of
eurospheres were more than proportionally higher at the
igh compared to the low densities. The fivefold increase in
ell density (from 10 to 50 cells/ml) produced a greater than
10-fold increase in the number of neurospheres generated,
thus demonstrating cell nonautonomous effects that facili-
tate neural stem cell proliferation.
The self-renewing capacity of the stem cells that formed
the neurospheres was assayed for at least one passage by
dissociating single spheres (Reynolds and Weiss, 1996)
isolated from low (0.6 ng/ml) and high (20 ng/ml) growth
factor concentration conditions from both low and high
density primary cultures, and counting the number of
secondary neurospheres generated. When single neuro-
spheres generated from high density cultures (50 cells/ml) in
0.6 ng/ml of EGF or FGF2 were dissociated in the same
growth factor conditions, new neurospheres were generated
d
t
Copyright © 1999 by Academic Press. All rightafter ;7 days in either EGF (9.3 6 1.7, n 5 8) or FGF2 (6.4 6
.8, n 5 8), respectively. Single neurospheres generated in
igh density cultures in 20 ng/ml of EGF or FGF2 were
FIG. 3. Dose-dependent proliferation of neural stem cells isolated
from the E14.5 and P3 forebrain GZ in EGF and FGF2 is sensitive
to cell density. Neurospheres generated from neural stem cells
isolated from the E14.5 GZ (n 5 6 embryos/concentration) and
plated at either a density of 50 cells/ml (A) or 10 cells/ml (B), and
rom neural stem cells from the P3 GZ (n 5 6 embryos/
oncentration) and plated at 10 cells/ml (C) in varying concentra-
ions (molarity) of EGF or of FGF2 with heparin.issociated, secondary neurospheres were generated in ei-
her EGF (19.6 6 3.9, n 5 8) or FGF2 (20.4 6 2.4, n 5 8),
s of reproduction in any form reserved.
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174 Tropepe et al.respectively. Similarly, in experiments where single neuro-
spheres generated from low density cultures (10 cells/ml) in
0.6 ng/ml of EGF or FGF2 were dissociated in the same
growth factor conditions, new neurospheres were generated
in either EGF (13.2 6 2.0, n 5 12) or FGF2 (5.0 6 1.3, n 5
2), respectively. Single neurospheres generated in low
ensity cultures in 20 ng/ml of EGF or FGF2 were dissoci-
ted, secondary neurospheres were generated in either EGF
16.5 1 2.6, n 5 12) or FGF2 (12.8 1 1.8, n 5 12),
espectively. Thus, the single neurosphere passaging data
emonstrate that individual neural stem cells, regardless of
ell density and growth factor concentration, can self-renew
nd expand the stem cell population through symmetrical
ivisions.
The proportionally greater maximal numbers of neuro-
pheres generated at high density (EGF or FGF2) reflects a
ell nonautonomous potentiation of neural stem cell pro-
iferation at higher densities. Furthermore, the greater
aximal numbers of neurospheres generated in FGF2 at
ow densities, compared to the same maximal number of
GF- and FGF2-generated neurospheres at high densities
Fig. 3B versus 3A), indicates that these cell nonautono-
ous effects may have a greater influence on EGF-
esponsive stem cell proliferation. The finding that low
ensity cultures appeared to produce a leftward shift from
igh density cultures in the dose-responsiveness of FGF2 on
14.5 neurosphere formation, compared to the relatively
table EGF dose-responsiveness regardless of cell density,
ay suggest that FGF2 has a greater affinity for its receptor
t lower densities. This may be due to the decreased
vailability of the FGF2 ligand (or heparin) at higher cell
ensities or perhaps due to the down regulation of FGF
eceptors on stem cells at high cell densities.
The relative number of stem cells present in higher cell
ensity cultures is greater than the number of stem cells in
ow density cultures. Since a relatively greater number of
eural stem cells also can be isolated from older than
ounger embryonic GZs (see above), it is possible that the
nteractions between the older stem and progenitor cells
ay facilitate the observed cell nonautonomous effects in
ivo, and that neural stem cells isolated from older GZ
issue and cultured at low densities will behave as neural
tem cells isolated from younger GZ tissue and cultured at
igher cell densities. In order to determine if the cell
ensity-dependent facilitation observed reflects an age-
ependent maturation phenomenon or is a true reflection of
tem and progenitor cell interactions dependent only on
ell density and not on age, we examined the dose-
ependent proliferation of neural stem cells isolated from
he postnatal day (P) 3 mouse forebrain at low densities.
he results demonstrate that the dose-dependent prolifera-
ion of neural stem cells isolated from the P3 GZ and
ultured at low densities is similar to the dose-dependent
roliferation of neural stem cells isolated from the E14.5
Z at low densities (Fig. 3C). These results show that the
ose-dependent proliferation of neural stem cells depends
p
E
Copyright © 1999 by Academic Press. All rightn cell density and not on the developmental stage at which
tem cells are analyzed.
To further determine that the concentration of exogenous
GF or FGF2 does not select for progenitor cells that are
ifferentially sensitive to varying growth factor concentra-
ions in these serum-free culture conditions, we used mi-
rowell culture dishes (see Materials and Methods) and
eeded E14.5 striatal GZ cells at clonal densities in various
oncentrations (0.6, 20, or 80 ng/ml) of either EGF or FGF2
eparately. Microwells containing 1–3 cells (6 h after plat-
ng) were followed for 7 days in order to assess neurosphere
ormation. Single primary neurospheres generated in these
onditions were dissociated and replated in the identical
rowth factor concentration conditions to determine the
elf-renewal capacity of the neurosphere forming cells.
ndividual primary neurospheres derived from single cells
n FGF2 (0.6, 20, or 80 ng/ml) demonstrated the ability to
enerate new (secondary) neurospheres upon dissociation in
ither 0.6 ng/ml (6.6 6 2.3 secondary neurospheres from
ach primary neurosphere, n 5 12), 20 ng/ml (29.9 6 7.9,
5 12), or 80 ng/ml (73.9 6 20.4, n 5 12) of FGF2.
imilarly, individual neurospheres derived from single cells
n EGF (0.6, 20, or 80 ng/ml) demonstrated the ability to
enerate secondary neurospheres upon dissociation in ei-
her 0.6 ng/ml (39.5 6 9.9, n 5 8), 20 ng/ml (81.4 6 24.2, n 5
1), or 80 ng/ml (83.4 6 18.2, n 5 10) of EGF. Moreover,
ndividual secondary neurospheres from each of these
rowth factor conditions demonstrated the ability to gener-
te tertiary neurospheres (in the identical growth factor
onditions) after a second passage. Individual secondary
eurospheres derived from single primary neurospheres in
GF2 (0.6, 20, or 80 ng/ml) demonstrated the ability to
enerate tertiary neurospheres upon dissociation in either
.6 ng/ml (3.0 6 0.7, n 5 5), 20 ng/ml (21.5 6 4.9, n 5 8), or
0 ng/ml (36.3 6 16.8, n 5 6) of FGF2. Similarly, individual
econdary neurospheres derived from single primary neuro-
pheres in EGF (0.6, 20, or 80 ng/ml) demonstrated the
bility to generate tertiary neurospheres upon dissociation
n either 0.6 ng/ml (12.3 6 3.2, n 5 6), 20 ng/ml (35.8 6
1.2, n 5 8), or 80 ng/ml (47.4 6 15.3, n 5 8) of EGF. All
rimary, secondary, and tertiary neurospheres generated in
.6 ng/ml FGF2 (and many, but not all in 0.6 ng/ml EGF)
ere smaller than the neurospheres generated in higher
rowth factor concentrations. Because the majority of the
ells within neurospheres express EGF and FGF receptors
see above), this likely reflects the inability of all of the cells
ithin the neurospheres to fully proliferate in these low
oncentration conditions and thus reducing the overall size
and number of stem cell progeny) of the neurospheres.
hese results show that single neural stem cells that
lonally generate neurospheres in varying concentrations of
rowth factors can self-renew.
In order to test that the self-renewing stem cells from
ifferent growth factor concentrations remain multipoten-
ial, single secondary neurospheres generated from the
rimary neurosphere cultures (microwell assay) in either
GF or FGF2 (from 0.6, 20, and 80 ng/ml conditions) were
s of reproduction in any form reserved.
a
d
t
r
s
f
O
b
a
t
F
s
p
i
s
furth
ndroc
175Growth Factor-Dependent Neural Stem Cell Proliferationallowed to differentiate in the identical growth factor con-
ditions on an adhesive substrate, which facilitates differen-
tiation of cells within the neurospheres (see below). Triple
immunolabeling for the presence of neurons (MAP21 cells),
strocytes (GFAP1 cells), and oligodendrocytes (O41 cells)
emonstrated that in virtually all growth factor concentra-
ion conditions, secondary neurospheres contained neu-
ons, astrocytes, and oligodendrocytes (Fig. 1C). These re-
ults are consistent with the immunostaining data (Table 1)
rom low cell density cultures (see below). However, no
41 oligodendrocytes were observed from secondary neu-
rospheres generated in 0.6 ng/ml of FGF2 and plated in 0.6
ng/ml of FGF2 (but can form if serum is present; see below).
This result is also consistent with the immunolabeling data
(Table 1) obtained from low density cultures in the same
growth factor concentration conditions without serum.
Therefore, neural stem cells proliferate in EGF and FGF2 to
form clonally derived neurospheres in a dose-dependent
manner and retain their self-renewing and multilineage
potential.
EGF and FGF2 Elicit Neural Stem Cell
Proliferation through Independent Signaling
Mechanisms
One possible explanation for the observed cell nonau-
tonomous proliferative effects at high densities may be that
in response to the application of exogenous growth factor,
neural stem cells regulate their proliferation through the
release of endogenous factors in an autocrine/paracrine
manner. For example, Kilpatrick and Bartlett (1995) dem-
onstrated that the proliferation of EGF-responsive E17 cor-
tical precursors could be attenuated with the addition of
inositol hexakisphosphate, which blocks the binding of
FGF2 to the extracellular domain of its receptor, suggesting
that the EGF-dependent proliferation of E17 cortical precur-
sors was also dependent upon the endogenous release of
FGF2. We asked whether neural stem cell proliferation in
the presence of exogenous EGF or FGF2 (the only known
critical mitogens for stem cell proliferation) was also depen-
TABLE 1
The Relative Proportions of Neuronal and Glial Progeny from Neu
Isolated and
differentiated in
Percentage of
neurons (n)
20 ng/ml EGF 6.1 1 0.7 (4)
0.6 ng/ml EGF 2.6 1 0.3 (6)
10 ng/ml FGF2 15.4 1 2.0 (5)
0.6 ng/ml FGF2 11.7 1 2.5 (6)
Note. Neural stem cells isolated from the E14.5 VZ in different co
transferred to coated coverslips and allowed to differentiate for a
processed for MAP2 (neurons), GFAP (astrocytes), and O4 (oligodedent upon the endogenous release of either FGF2 or EGF,
respectively.
Copyright © 1999 by Academic Press. All rightWe utilized E14.5 EGF-receptor null (EGFR(2/2)) embryos
(Fig. 4A) (Sibilia and Wagner, 1995) and tested whether
neural stem cell proliferation in FGF2 was attenuated in an
EGFR(2/2) background. The number of neurospheres gener-
ated from high density (50 cells/ml) cultures of E14.5 VZ
from EGFR(2/2) mice in the presence of EGF was decreased
by greater than 90% compared to littermate EGFR(1/1)
controls (P , 0.05); however, the generation of large num-
ers of neurospheres in the presence of FGF2 was not
ffected in these mutants (Fig. 4B). This result indicates
hat the endogenous release of EGF was not necessary for
GF-dependent neural stem cell proliferation, but that
ignaling through the EGFR was critical for EGF-dependent
roliferation.
Neural tissue malformation and early embryonic lethal-
ty precluded an analysis of EGF- and FGF-dependent neural
tem cell proliferation in FGFR1(2/2) E14.5 mouse GZ (Deng
et al., 1994; Yamaguchi et al., 1994). However, utilizing
tetraploid chimeric mutant mice (ROSA26-FGFR1(2/2)) with
a transient rescue of the early embryonic phenotype (due to
the tetraploid dominance of extraembryonic tissue) (Ciruna
et al., 1997), we observed a large attenuation (approximately
80% decrease) in the number of neural stem cells prolifer-
ating in the presence of FGF2 from at E8.5 (Fig. 4C). The
lack of a complete attenuation in neurosphere formation in
the ROSA26-FGFR1(2/2) mutant may indicate that FGF2
may also produce a minor activation of other members of
FGF receptor family at this early stage of development.
Nonetheless, signaling through the FGFR1 is critical for
most FGF2-dependent neural stem cell proliferation.
In order to more clearly define the role for endogenous
growth factor release, we further tested if the secondary
release of FGF2 upon EGF stimulation, and vice versa,
affected neural stem cell proliferation by blocking FGF2
signaling with an anti-FGF2 neutralizing antibody (Matsu-
zaki et al., 1989), which prevents the ligand from binding to
its receptor, and blocking EGF signaling with a synthetic
EGFR inhibitor (PD 153035), which selectively disables
EGF signaling by binding to the tyrosine kinase domain of
the EGFR (Fry et al., 1994). The number of neurospheres
tem Cells Isolated in Different Growth Factor Concentrations
Percentage of
astrocytes (n)
Percentage of
oligodendrocytes (n)
56.3 1 6 (6) 2.6 1 0.3 (3)
54.1 1 3.7 (6) 0.7 1 0.2 (6)
56.4 1 5.3 (6) 1.9 1 0.3 (5)
57.8 1 7.9 (4) 0.0 1 0.0 (6)
trations of EGF or FGF2 were cultured for 6 days in vitro and then
er 7 days in the same growth factor conditions. Coverslips were
ytes) using immunocytochemistry.ral S
ncengenerated from high density (50 cells/ml) cultures of E14.5
GZ in the presence of FGF2 and anti-FGF2 antibody (1.25
s of reproduction in any form reserved.
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Copyright © 1999 by Academic Press. All rightmg/ml) was decreased by almost 100% (P , 0.05), compared
o the number of neurospheres generated in the presence of
GF2 and a nonspecific control antibody (matched for
pecies and isotype similarity) (Fig. 5A). However, there was
o difference in the number of neurospheres generated in
he presence of EGF and the anti-FGF2 antibody, compared
o controls in EGF (Fig. 5A). The EGFR inhibitor (0.16 mM)
did not block neural stem cell proliferation in the presence
of FGF2, but was effective in eliminating neural stem cell
proliferation in the presence of EGF (Fig. 5B). These results
show that EGF and FGF2 stimulate neural stem cell prolif-
eration in high density cultures through completely inde-
pendent signaling mechanisms.
To determine if the cell nonautonomous effects that
increased neural stem cell proliferation at high cell densi-
ties obscured any putative endogenous EGF or FGF2 signal-
ing in response to exogenous growth factor, we tested the
effects of blocking EGF signaling (EGFR inhibitor) or FGF2
signaling (anti-FGF2 antibody) in lower cell density cul-
tures (10 cells/ml), where the influence of these cellular
interactions on neurosphere formation is less. A similar
result was observed when the same experiment was per-
formed at cell plating densities of 1 cell/ml, a condition that
diminishes the cell nonautonomous effects even further
(data not shown). Therefore, the results demonstrate that
even at low cell density, secondary release of FGF2 in
response to EGF (Fig. 5C) or secondary release of EGF in
response to FGF2 (Fig. 5D) does not contribute to the
numbers of neural stem cells that proliferate to form
neurospheres in vitro. Thus, the facilitative cell nonau-
tonomous effects at either high (50 cells/ml) or lower (10
ells/ml) cell densities are likely due to additional unknown
ndogenous factors and not due to endogenous EGF or FGF2
ignaling. High cell density E14.5 GZ cultures sometimes
esults in a very small number of neural stem cells clonally
roliferating to form neurospheres in the presence of serum-
ree media without exogenous growth factors (3.8 6 1.2, n 5
6), which is never observed at lower cell densities. Thus,
although the unknown mitogenic factor(s) that mediate this
proliferation are not sufficient alone to account for the
robust facilitative cell nonautonomous effects observed in
the presence of exogenous EGF or FGF2, this does not
preclude the possibility that these unknown factors may
interact with the exogenous growth factors to substantially
enhance neural stem cell proliferation.
from neural stem cells isolated from the E8.5 anterior neural plate
of ROSA26-FGFR1(1/2) tetraploid chimeric (controls; n 5 24) or
OSA26-FGFR1(2/2) tetraploid chimeric (n 5 25) embryos andFIG. 4. Neural stem cells proliferate independently of EGFR
signaling in response to FGF2, but FGFR1 signaling is critical for
FGF2-dependent neural stem cell proliferation. (A) The panel
shows PCR analysis of genomic DNA isolated from E14.5 EGFR
(1/1), (1/2), and (2/2) mice. The expected mutant (1.8 kb) and
wild-type (1.3 kb) bands are indicated. (B) Neurospheres generated
(mean as a percentage control 6 SEM) from neural stem cells
isolated from the E14.5 GZ of EGFR (2/2) (n 5 5) and EGFR (1/1)
(n 5 6) embryos and plated at 50 cells/ml in the presence of EGF (20
g/ml) (white bars) or FGF2 (10 ng/ml) with heparin (black bars).
he 100% control represents the numbers of neurospheres gener-lated at 10 cells/ml in the presence of FGF2 (10 ng/ml) with
eparin.
s of reproduction in any form reserved.
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177Growth Factor-Dependent Neural Stem Cell ProliferationGrowth Factor Concentration Has Little Effect on
the Relative Fates of Neural Stem Cell Progeny
It has been shown previously that the levels of growth
factor receptors and their ligands are dynamic throughout
development. For example, levels of FGF2 increase during
embryogenesis (Powell et al., 1991; Nurcombe et al., 1993;
Weise et al., 1993). The present findings that the numbers
of neural stem cells isolated from the developing telenceph-
FIG. 5. Endogenous release of EGF or FGF2 does not influence neu
neural stem cells isolated from the E14.5 GZ in the presence of the a
of FGF2 (10 ng/ml) with heparin compared to control (conAb and F
control (conAb and EGF), at 50 cells/ml (A) or 10 cells/ml (C) plating
GFR inhibitor (0.16 mM PD) is also substantially decreased in th
resence of FGF2 and heparin compared to control (DMSO 1 FGF2
growth factor condition group at both high and low cell densities.alon increase during development and that growth factor
concentration can modulate neural stem cell proliferation
Copyright © 1999 by Academic Press. All righteven at one stage of development, suggests that growth
factor concentration may regulate neural stem cell prolif-
eration in vivo. Having shown that neural stem cell prolif-
eration is influenced by EGF and FGF2 concentration, we
investigated whether growth factor concentration had any
influence on the fates of the stem cell-derived progeny.
Previous work has revealed that FGF2 influences the
types of progeny generated from E10 cortical precursor cells
tem cell proliferation. The number of neurospheres generated from
GF2 antibody (1.25 mg/ml) is substantially reduced in the presence
1 heparin), but not in the presence of EGF (20 ng/ml) compared to
ities. The number of neurospheres generated in the presence of the
sence of EGF compared to control (DMSO 1 EGF), but not in the
eparin), at 50 cells/ml (B) or 10 cells/ml (D). n 5 6 embryos for eachral s
nti-F
GF2
dens
e prein a concentration-dependent manner (Qian et al., 1997).
When our neural stem cell-derived neurospheres are plated
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178 Tropepe et al.on an adhesive substrate, then the cells will adhere and in
the presence of fetal bovine serum will differentiate into
neurons, astrocytes, and oligodendrocytes expressing
phenotype-specific markers. Neurospheres that were gener-
ated from the E14.5 striatal GZ in the presence of optimal
concentrations of either EGF (20 ng/ml) or FGF2 (10 ng/ml),
or low concentrations of either growth factor (0.6 ng/ml)
demonstrated multipotentiality when cultured in the pres-
ence of media containing fetal bovine serum (data not
shown). In order to address the effect of EGF and FGF2 on
the generation of neurons and glia independent of any
unknown factors present in serum, we isolated EGF- and
FGF-responsive neural stem cells (at low cell densities) in
either high or low concentrations of growth factor and then
allowed for differentiation in the same serum-free condi-
tions. The data show that independent EGF- and FGF-
responsive primary neural stem cells both demonstrate
multilineage potential, regardless of growth factor concen-
tration (Table 1). These results are consistent with the
results from the growth factor dose-dependent clonal anal-
yses (see above). The proportion of neurons and oligoden-
drocytes decreased in the presence of lower concentrations
of either EGF or FGF2, but the proportion of astrocytes
(approximately 55%) remained constant. In low concentra-
tions of FGF2 the percentage of O41 oligodendrocytes in the
sampled cells was zero. However, since there is an obvious
trend for a reduction in differentiated oligodendrocytes in
low concentrations of both EGF and FGF2, we suggest that
these conditions were likely not permissive for oligoden-
drocyte differentiation. Certainly, neurospheres generated
in low concentrations of FGF2 and allowed to differentiate
in the presence of low concentrations of FGF2 and 10% FBS
also produce a very small percentage of O41 cells (data not
shown). Neurospheres plated in FGF2 generate more neu-
rons compared to neurospheres plated in EGF (Table 1),
which may suggest that FGF2-responsive stem cells are
specified to produce more neurons than EGF-responsive
stem cells. However, we cannot rule out the perhaps more
likely possibility that the growth factors were influencing
the progeny of the stem cells (rather than the stem cells
themselves) in a selective manner. Thus, although neural
stem cell proliferation is regulated by growth factor concen-
tration, both EGF- and FGF-responsive neural stem cells
maintain their multilineage potential in the presence of
varying growth factor concentrations.
Neural Stem Cell Proliferation Is Additive with the
Combination of EGF and FGF2 at Low Cell
Density
Neural stem cells present in the E14.5 GZ have EGF and
FGF2 receptor signaling capacity, and either factor alone is
sufficient to activate neural stem cell proliferation in
serum-free, defined media. To determine directly the sen-
sitivity of neural stem cell proliferation to EGF or FGF2, we
assayed the numbers of neurospheres generated in the
presence of EGF, FGF2, and the combination of both mito-
c
a
Copyright © 1999 by Academic Press. All rightens at very low cell plating densities. The numbers of
eurospheres generated in the presence of FGF2 was greater
han the number of neurospheres generated in the presence
f EGF from 1 cell/ml to 10 cells/ml (Fig. 6A). This observa-
tion is consistent with the previous finding that at a lower
cell density (10 cells/ml) and optimal concentrations of EGF
(20 ng/ml) and FGF2 (10 ng/ml) a greater number of neuro-
spheres are generated in FGF2. Furthermore, from 1 cell/ml
to 10 cells/ml the number of neurospheres generated in the
ombination of EGF and FGF2 was additive (Fig. 6A).
onversely, the numbers of neurospheres generated in EGF
r FGF2 at optimal concentrations and high cell plating
ensity (50 cells/ml) were equivalent (Fig. 3A). We further
xamined the role of facilitative cell nonautonomous ef-
ects on neural stem cell proliferation over the lower range
f cell densities (1 versus 10 cells/ml) by plating the same
small absolute number of cells (2000) in different volumes.
Neural stem cell proliferation was increased more than
10-fold in EGF and in FGF2 at the higher density when the
same absolute numbers of cells were plated in different
volumes (Fig. 6B). Therefore, all of these data suggest that
neural stem cells may have a differential sensitivity to EGF
and FGF2, which can be revealed over relatively low cell
densities, but that is obscured at high cell densities due to
additional cell nonautonomous effects produced by the
release of unknown endogenous growth factors.
One possible interpretation for the enhanced prolifera-
tion of neural stem cells in the presence of combined EGF
and FGF2 compared to either factor alone over all of the
lower cell densities (Fig. 6A) is that EGF and FGF2 interact
synergistically to elicit a stem cell to divide. To test this
possibility, high and low growth factor concentrations were
combined to determine if the number of E14.5 neural stem
cell-derived neurospheres was greater than additive (i.e.,
substantially greater than the estimated number of neuro-
spheres generated when adding the numbers of neuro-
spheres seen when only a single high or low growth factor
concentration was present). The combination of high and
low concentrations of EGF and FGF2 did not appear to
interact synergistically to promote neural stem cell prolif-
eration (Fig. 6C). These data argue that EGF and FGF2 can
independently elicit the proliferation of EGF- and FGF-
responsive stem cells.
One possible explanation for the additivity in the number
of neurospheres generated at low cell densities in the
presence of the combined growth factors (and lack of
synergy) is that there are separate populations of neural
stem cells that are responsive to either EGF or FGF2. To
further test the putative heterogeneity in the neural stem
cell population we estimated the minimal frequency of
neural stem cells at limiting dilutions. The lack of specific
morphological or biochemical criteria for identifying neural
stem cells in vivo presents a major problem when attempt-
ng to determine the frequency of stem cells in the GZ.
urrently, the best biochemical marker for neural precursorells is the intermediate filament protein nestin (Lendahl et
l., 1990); however, it is not specific to neural stem cells
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179Growth Factor-Dependent Neural Stem Cell Proliferationand is expressed in other cell types including developing
cardiac cells (Zimmerman et al., 1994) and neural progeni-
ors. We took advantage of the neurosphere assay, in which
ne neurosphere represents the proliferation of a single
elf-renewing, multipotential neural stem cell (Reynolds
nd Weiss, 1996), and applied a limiting dilution analysis
Lefkovits and Waldmann, 1984; Sharrock et al., 1990;
ellows and Aubin, 1989) in order to determine the specific
requency of neural stem cells (among a population of VZ
eural precursors) that proliferate in response to either EGF,
GF2, or the combination of EGF and FGF2. The linear
FIG. 6. At low cell densities, the frequency of E14.5 neural stem
presence of EGF plus FGF2. (A) When decreasing numbers of cells
in the presence of both EGF (20 ng/ml) and FGF2 (10 ng/ml) with he
factor alone at all cell densities tested (equal to and less than 10 cell
in different volumes, a substantial facilitative community effect wa
in both EGF and FGF2 was additive compared to other growth fac
concentrations of growth factors, EGF and FGF2 do not interact sy
at limiting dilution (in 200 ml vol of media) revealed that the freq
eurosphere (37% mark on the y axis) varied in the presence of eithe
5 6–7 embryos for each cell density and growth factor conditionelationship between the percentages of wells without
eurospheres and the numbers of cells plated per well
Copyright © 1999 by Academic Press. All rightuggest that separate single neural stem cells are proliferat-
ng in EGF and FGF2 to give rise to neurospheres. When
lating at limiting dilutions, the proportion of culture wells
ith no neurospheres (i.e., negative wells) is defined by the
ero term of the Poisson distribution: F0 5 e2x. The number
f cells required to allow for the isolation of one stem cell
x 5 1) can be calculated using F0 5 e21 5 0.37 or 37%. Based
on the Poisson distribution and the intersect at the 37%
level, we estimated the minimal frequency of neural stem
cells in the E14.5 VZ precursor population to be 0.6% in the
presence of EGF, 1.3% in the presence of FGF2, and 2%
varies in EGF and FGF2 alone and proliferation is additive in the
plated in 200 ml of media the number of neurospheres generated
was additive compared to the numbers generated in either growth
(B) When the same absolute number of cells (2000 cells) was plated
erved, and at both densities the number of neurospheres generated
alone. (C) When cells are plated (10 cells/ml) in varying combined
stically to promote neural stem cell proliferation. (D) Cells plated
y in which at least one neural stem cell will proliferate to form a
F (20 ng/ml), FGF2 (10 ng/ml) with heparin, or both EGF and FGF2.
all four experiments.cells
were
parin
s/ml).
s obs
tors
nergi
uenc(additive) in the presence of both EGF and FGF2 combined
(Fig. 6D). These data reveal that there are separate EGF- and
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180 Tropepe et al.FGF-sensitive populations of embryonic telencephalic neu-
ral stem cells.
EGF-Responsive Neural Stem Cells Are Lineage
Descendents of FGF2-Responsive Neural Stem
Cells
The above experiments revealed that EGFR and FGFR1
signaling is critical for EGF- and FGF2-dependent neural
stem cell proliferation, respectively, and that FGF- and
EGF-responsive neural stem cells may represent two sepa-
rate subpopulations within the E14.5 GZ. Because both
FGFR1(2/2) embryos and ROSA26-FGFR1(2/2) tetraploid chi-
meras die by approximately E9.5, in order to determine if a
lineage relationship exists between FGF-responsive neural
stem cells and EGF-responsive neural stem cells (which
normally do not begin to emerge until E11.5–E13.5 in the
striatal GZ) we generated diploid chimeras in which wild-
type cells (CD1) allowed the embryos with cells harboring
an FGFR1(2/2) mutation to survive until E14.5. We hypoth-
sized that if the EGF-responsive neural stem cells arose
ndependently of the FGF2-responsive neural stem cells
uring development, then an FGFR1 null mutation would
ot influence the numbers of EGF-responsive stem cells
solated, but would cause an attenuation of the FGF2-
esponsive stem cells (similar to what was observed from
he E8.5 ROSA26-FGFR1(2/2) tetraploid chimera results).
The relative contribution (percentage chimerism) of cells
rom either the ROSA26-FGFR1(2/2) lineage or the ROSA26-
GFR1(1/2) lineage in the diploid chimeras was estimated
rom histological sections on the basis of b-galactosidase
(b-gal) staining (Fig. 7A). Single hemispheres obtained from
E14.5 telencephalons from ROSA26-FGFR1(1/2) diploid chi-
meras (controls, n 5 8) demonstrated a mean percentage
chimerism of 34.8% within the striatal GZ, while those
obtained from ROSA26-FGFR1(2/2) diploid chimeras (n 5 8)
emonstrated a mean percentage chimerism of 12.4%
ithin the striatal GZ. These estimates are consistent with
revious chimerism data from diploid chimeric embryos
nalyzed between E9.5 and E10.5, showing that fewer
utant cells (compared to controls) contribute to anterior
eural structures (Ciruna et al., 1997). Cells isolated from
he striatal GZs of the opposite hemispheres were cultured
n serum-free conditions in the presence of optimal concen-
rations of either FGF2 (10 ng/ml) or EGF (20 ng/ml). The
umbers of b-gal1 neurospheres (containing all blue cells
derived from either the ROSA26-FGFR1(2/2) stem cells or
erived from the ROSA26-FGFR1(1/2) stem cells) and the
numbers of b-gal2 neurospheres (containing all white cells
derived from wild-type CD1 stem cells) were quantified
after 7 days in culture (Fig. 7B). The results show that the
proliferation of both FGF- and EGF-responsive neural stem
cells is decreased by greater than 95% in E14.5 ROSA26-
FGFR1(2/2) diploid chimeras (n 5 8) compared to ROSA26-
FGFR1(1/2) diploid chimeric controls (n 5 8) (Fig. 7C). Theumber of neurospheres generated in both EGF and FGF2 is
nhanced by ;50% and by over twofold, respectively, from
r
o
Copyright © 1999 by Academic Press. All rightild-type CD1-derived neural stem cells (b-gal2) in the
ROSA26-FGFR1(2/2) diploid chimeras compared to the
ROSA26-FGFR1(1/2) diploid chimeric controls (Fig. 7C).
This suggests that in these diploid chimeras, wild-type
neural stem cells can partially compensate for the overall
reduction in the numbers of neural stem cells in the GZ in
vivo by increasing their symmetrical divisions prior to
E14.5. However, since there is an overall 50% decrease in
the total number of neurospheres generated from the
ROSA26-FGFR1(2/2) diploid chimeras (ROSA and CD1 com-
bined) compared to the ROSA26-FGFR1(1/2) diploid chi-
meric controls (data not shown), this increase in the num-
ber of neurospheres in vitro may only represent a very
minor compensatory effect. Thus, these results are consis-
tent with the hypothesis that EGF-responsive neural stem
cells are lineage descendents of the FGF-responsive neural
stem cells during telencephalic development.
DISCUSSION
Simple neural lineage models depict a single self-
renewing, multipotential stem cell giving rise to progenitor
cells that are more restricted in their potential to generate
differentiated neurons, astrocytes, and oligodendrocytes,
depending on factors that influence either their prolifera-
tion, differentiation, or survival (Gage et al., 1995; Temple
and Qian, 1995; Johe et al., 1996; Weiss et al., 1996). The
resent data builds upon this fundamental notion to sup-
ort an alternative model in which separate, lineage-related
tem cells are also present in the E14.5 GZ (Fig. 8). This
onclusion is based on the evidence that: (1) only FGF-
esponsive neural stem cells are present at early develop-
ental stages, but these cells can generate EGF-responsive
tem cells when passaged in vitro and EGF-responsive stem
ells can be isolated at later developmental stages in vivo;
2) at low cell densities greater numbers of neural stem cells
roliferate in response to FGF2 than to EGF; (3) neural stem
ell proliferation is additive in the presence of both mito-
ens; (4) there is a differential frequency of EGF- and
GF-responsive stem cells at limiting dilutions, suggesting
hat these two stem cell populations are separate; and (5) a
utation in the FGFR1 gene which prevents the expansion
f the FGF2-dependent neural stem cells during telence-
halic development also prevents the emergence of the
GF-responsive neural stem cells. Unknown endogenous
actors (other than EGF or FGF2) can facilitate the prolif-
ration of FGF- and especially EGF-responsive subpopula-
ions to form neurospheres, and at higher cell densities
erve to obscure the differences between the EGF- and
GF-responsive stem cells. Despite the presence of separate
GF- and FGF-responsive stem cells, both types are self-
enewing and capable of generating neurons, astrocytes, and
ligodendrocytes.
s of reproduction in any form reserved.
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181Growth Factor-Dependent Neural Stem Cell ProliferationFIG. 7. In ROSA26-FGFR1(2/2) diploid chimeras, both FGF2- and EGF-responsive neural stem cell proliferation is diminished from E14.5
striatal GZ cells harboring the FGFR1(2/2) mutation. (A) Lateral view of an E14.5 left hemisphere (rostral end to the left) stained with X-gal
depicting the chimeric pattern of cells with either a transgenic ROSA26-FGFR1(1/2) genetic background (b-gal1 cells appear blue with the
X-gal histochemical reaction) or a wild-type CD1 genetic background (nonstaining white cells). Large, solid arrow pointing to the forebrain;
open arrow pointing to the midbrain; small, solid arrow pointing to the spinal cord. (B) Neurospheres generated from single E14.5 striatal
GZ stem cells after 7 days in vitro in the presence of 10 ng/ml FGF2, and subsequently processed for X-gal staining. The stem cell clone
(neurosphere) with a ROSA26-FGFR1(1/2) genetic background expressed b-gal and stained blue throughout with the histochemical
reaction. The stem cell-derived neurosphere with a wild-type CD1 genetic background did not express b-gal and did not stain
istochemically (with phase-contrast, cells in the center of the sphere appear slighter darker, which may be due to partial necrosis of cells
hat are situated deep within relatively large spheres). The photographs of these two neurospheres were taken from a single culture. (C)
eurospheres generated (mean as a percent control 6 SEM) from neural stem cells isolated from the E14.5 GZ of ROSA26-FGFR1(1/2)
iploid chimeric mice (n 5 8) and ROSA26-FGFR1(2/2) diploid chimeric mice (n 5 8) and plated in duplicate at 10 cells/ml in the presence
f EGF (20 ng/ml) or FGF2 (10 ng/ml) with heparin. The 100% control represents the numbers of neurospheres generated from
OSA26-FGFR1(1/2) diploid chimeric mice (controls). From these control mice, neurospheres were derived from stem cells with either a
OSA26-FGFR1(1/2) genetic background [black bars, (1/2) beta-gal1] or from stem cells with a wild-type CD1 genetic background [white
bars, (1/2) beta-gal2] in either EGF or FGF2 and heparin. In ROSA26-FGFR1(2/2) diploid chimerias, neurospheres were derived from stem
cells with either a ROSA26-FGFR1(2/2) genetic background [striped bars, (2/2) beta-gal1] or from stem cells with a wild-type CD1 genetic
background [stippled bars, (2/2) beta-gal2]. Scale bars: A, 10 mm; B, 100 mm.
Copyright © 1999 by Academic Press. All rights of reproduction in any form reserved.
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182 Tropepe et al.A Neural Stem Cell That Proliferates in Response
to FGF2 Emerges Earliest in Embryonic
Telencephalic Development
The expression of FGFR1 within the E8.5 neural plate
indicates that neuroepithelial cells at this early stage of
development are competent to proliferate in response to
FGF2, the primary ligand for this FGFR subtype (Ornitz and
Leder, 1992; Johnson and Williams, 1993). Using the in
itro clonal neurosphere assay for neural stem cells, we
howed that only FGF-responsive neural stem cells are
resent as early as E8.5 within the anterior neural plate,
ear the onset of neural development in the postgastrulat-
ng mouse embryo. The substantial attenuation of E8.5
eural stem cell proliferation observed in mice lacking a
unctional FGFR1 (ROSA26-FGFR1(2/2) tetraploid chimeras)
uggests that the mitogenic signal provided by FGF2 is
rimarily mediated by FGFR1. However, FGF2 may also
ignal through other FGFR family members to cause a small
ercentage of the FGF2-dependent neural stem cells to
roliferate at this early stage of neural development. For
xample, FGFR2 has been shown to be expressed in the
arly embryonic GZ (Orr-Urtreger et al., 1991). The neuro-
pheres generated in FGF2 can be subcloned in vitro in the
resence of EGF or FGF2, suggesting that the FGF-
FIG. 8. Model of EGF- and FGF-dependent proliferation of neur
eural stem cells at E8.5 are the lineage precursors to the EGF
GF2-responsive subpopulations are present in the E14.5 GZ. Se
ubpopulations.esponsive neural stem cells are the lineage precursors to
he EGF-responsive neural stem cells. Our evidence from
t
E
Copyright © 1999 by Academic Press. All righthe ROSA26-FGFR1(2/2) mouse diploid chimeric analyses
demonstrates that this lineage relationship between FGF-
responsive and EGF-responsive neural stem cells also exists
in vivo. Since both EGF- and FGF-responsive neural stem
cells that contained the FGFR1(2/2) mutation were signifi-
cantly diminished from the E14.5 striatal GZ, our data
strongly suggest that the ontogeny of the EGF-responsive
neural stem cell is not independent of the FGF2-responsive
neural stem cell, but rather that the FGF2-responsive neural
stem cell gives rise to the EGF-responsive neural stem cell
during telencephalic development. It is possible that the
FGF-responsive stem cell population secretes an unknown
factor that is necessary to promote the development of an
EGF-responsive stem cell population. However, this is
unlikely since we would expect that in the diploid chimeric
mice, the FGF-responsive stem cells with the wild-type
CD1 background would be able to provide this unknown
factor to allow the ROSA26-FGFR1(2/2) (or ROSA26-
GFR1(1/2) control) cells to proliferate in response to EGF at
14.5. The neural stem cell-derived neurospheres in the
resent study also demonstrate multilineage potential (gen-
rating neurons, astrocytes, and oligodendrocytes), confirm-
ng their stem cell status. There is a ;7-fold increase in the
umber of neural stem cells (in similar cell density cul-
m cells during telencephalic development. The FGF2-responsive
onsive stem cells and both of the relatively separate EGF- and
ewal capacity and multilineage potential is maintained in bothal ste
-respures) isolated between E8.5 (anterior neural plate) and
14.5 (striatal GZ) in the present study. The estimated
s of reproduction in any form reserved.
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183Growth Factor-Dependent Neural Stem Cell Proliferationfrequency of neurosphere-forming stem cells as a percent-
age of the total viable GZ cells cultured in vitro increases
from ;0.3% at E8.5 to at least 2% at E14.5. Since only the
striatal GZ was used to determine stem cell frequency at
E14.5 and not the cortical GZ (the other major derivative of
the anterior neural plate), the magnitude of the increase in
neural stem cell frequency may be underestimated. None-
theless, these results reveal that the neural stem cell
population substantially expands through symmetrical di-
visions within the GZ throughout the early stages of
telencephalic development. These initial observations pro-
vide a basis for further examining when and to what extent
symmetrical stem cell divisions occur during this time
period.
Between E13.5 and E15.5 there is an increase in the EGF
responsiveness of neural stem cells isolated from the corti-
cal GZ and striatal GZ. An early FGF2 responsiveness of
neural precursors has been observed in multipotential pre-
cursors from the E10 telencephalon (Kilpatrick and Bartlett,
1993) and neural stem cells from the E10 spinal cord
(Kalyani et al., 1997). Different regions of the developing
telencephalon are known to have a differential pattern of
maturation. There is evidence for caudorostral and ventro-
dorsal gradients of maturation in the forebrain, with the
most rostral (olfactory bulbs) and most dorsal (cortex)
regions developing last (Smart and Smart, 1982). The ab-
sence of substantial EGF-responsiveness of neural stem
cells may reflect the “immaturity” of this telencephalic
region. The stronger expression of the EGFR in ventral
forebrain regions at early stages is consistent with this
possibility (Eagleson et al., 1996). One possible mechanism
for the increased responsiveness to EGF may involve the
upregulation of EGFR expression. In accordance with this
interpretation, Burrows et al. (1997) have shown that very
few stem cells present in the E12–E15 rat cortical germinal
zone normally proliferate in response to EGF, which is
ontologically similar to the E10–E13 mouse cortical germi-
nal zone. However, when the number of EGFRs is increased
in these cells using a retroviral construct then neural stem
cell proliferation in response to EGF is enhanced at these
early ages. This suggests that a critical ratio of ligand:
receptor was necessary to elicit EGF-dependent prolifera-
tion of neural stem cells that were present, but relatively
unresponsive (Burrows et al., 1997). If only a single stem
cell population exists, then an enhanced EGF response in
the EGFR-transfected cells could be interpreted as the
precocious response of a single stem cell to EGF. However,
it is equally plausible that if separate EGF- and FGF-
responsive stem cell populations were present in the GZ,
both types of stem cells can be transfected with the EGFR
construct, enhancing their responsiveness to EGF. Indeed,
one novel prediction from the present results is that if both
EGF- and FGF-responsive stem cells can be transfected with
the EGFR construct, then the additive effects on neuro-
sphere formation at cell low densities in the presence of
EGF and FGF2 combined would disappear.
The FGFR1(2/2) mutation is embryonic lethal (between
Copyright © 1999 by Academic Press. All right7.5 and E9.5) and mutant mice demonstrate severe axial
atterning defects (Deng et al., 1994; Yamaguchi et al.,
994). Embryos with a less severe phenotype at E8.5 dis-
layed relatively small and disorganized neural folds
Yamaguchi et al., 1994). This suggests that although cells
f the dorsal midline ectoderm are specified to become
eural, the FGFR1(2/2) neural stem cells present at this early
tage of development may be unable to proliferate in
esponse to FGF2 to expand the population, which may be
necessary antecedent to neurogenesis. Our present results
eveal that FGFR1 is critical not only for FGF2-dependent
roliferation of neural stem cells at E8.5, but also for the
xpansion of this population throughout telencephalic de-
elopment. The EGFR(2/2) lethal phenotype, on the other
and, was dependent on genetic background, with the age of
eath ranging from implantation to postnatal day 20 (Miet-
inen et al., 1995; Sibilia and Wagner, 1995; Threadgill et
l., 1995). Epithelial proliferation and differentiation were
ompromised in many tissues. Neural development in early
tages of embryogenesis was relatively spared, but by E18
here appeared to be reduced cortical size in both the
erebrum and cerebellum, with a concomitant GZ expan-
ion (Threadgill et al., 1995). The EGFR(2/2) mutation ap-
eared to affect multiple mechanisms (including cell sur-
ival, proliferation, differentiation, and migration)
egulating neuronal and glial cell types (Sibilia et al., 1998).
he present results show that the EGF-induced prolifera-
ion of neural stem cells isolated from the EGFR(2/2) fore-
rain GZ is drastically reduced, but that FGF-
esponsiveness of neural stem cells in these mutant mice is
ot affected. Since early neural development is apparently
ormal in these mutants, these results indicate that EGF-
esponsiveness of neural stem cells is not necessary at early
tages, but may subsequently be required for the production
f progenitor cells at later stages of development (as judged
y the late neural phenotype in the EGFR(2/2) mice). Fur-
hermore, it will be important to determine if the progeni-
or cells produced by telencephalic stem cells are dependent
pon EGF for the proper production of neurons and glia
rom older embryonic and early postnatal periods, when the
GF-dependent neurodegeneration is most prevalent
Sibilia et al., 1998).
Separate EGF- and FGF-Responsive Neural Stem
Cell Populations Coexist at Later Stages of
Telencephalic Development
There are two possible mechanisms by which FGF2 and
EGF can influence neural stem cell proliferation at different
stages of development. The first is that the neural stem cell
possesses only FGFR1 signaling at E8.5, but by E14.5–15.5
has developed both EGFR and FGFR1 signaling capacity,
either of which alone may be sufficient to activate the
neural stem cell. It is conceivable that the differences in
EGF- and FGF2-dependent proliferation may actually re-
flect the ability of these mitogens to regulate later progeni-
tor cell proliferation within a stem cell lineage (neuro-
s of reproduction in any form reserved.
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184 Tropepe et al.sphere), rather than differentially influencing two separate
stem cell populations to divide. These differences, however,
would still support the notion that neural stem cell lineages
can be differentially regulated by EGF and FGF2. The
second possibility is that the FGF-responsive neural stem
cell at E8.5 is the precursor in a lineage to the EGF-
responsive stem cell, but that both of the separate EGF- and
FGF-responsive neural stem cells are present in the E14.5–
15.5 GZ (Fig. 8). Indeed, this hypothesis is strongly sup-
ported by our analysis of the ROSA26-FGFR1(2/2) diploid
chimeras. Although EGFR and FGFR expression appears to
be ubiquitous among neural stem cells and their progeny in
primary neurospheres, the variation in receptor expression
within individual cells provides at least some initial cor-
relative evidence to suggest that cells which express mostly
EGFR or mostly FGFR are maintained as differentially
responsive cells, and perhaps some of which may be stem
cells with the capacity to self-renew. It is clear from the
present results that neural stem cell proliferation in EGF or
FGF2 is concentration-dependent, and others have shown
that stem cell proliferation in the presence of EGF also
depends on the levels of EGFR (Burrows et al., 1997). The
fact that high levels of EGFR are required for some neural
stem cells to divide (Burrows et al., 1997) offers the possi-
ility that cells expressing high levels of one receptor
roliferate in the presence of ligand in a concentration-
ependent manner, but that low levels of the other receptor
ender the cells unresponsive regardless of ligand concen-
ration.
Previous reported estimates of the frequency of FGF2-
esponsive multipotential precursor cells in the embryonic
orebrain ranged from approximately 4% (at E10) to 5% (at
17) (Kilpatrick and Bartlett, 1995). On the other hand, the
requency of E12 and E14 cortical GZ cells isolated in
onditioned media with the characteristics of stem cells
as approximately 7% (Davis and Temple, 1994). Limiting
ilution analyses revealed that the minimal frequency of
eural stem cells in the E14.5 GZ is 0.6% in the presence of
GF, 1.3% in the presence of FGF2, and 2% in the combi-
ation of EGF and FGF2, and indicates that stem cells are
ifferentially recruited on the basis of what growth factor is
resent. The higher frequencies reported by others may
ave included progenitor cells as well as true stem cells.
lternatively, our estimated frequencies of stem cells using
imiting dilution may be low because of the present finding
hat cell nonautonomous effects of cell density, that are not
ue to the endogenous release of EGF or FGF2, more than
roportionally increase the number of stem cells. Thus, cell
lating density is a critical variable when determining
aximal stem cell frequency. Nonetheless, all of these
stimates reveal that the stem cell pool makes up only a
mall percentage of the total GZ precursor population. The
resent data suggest a large increase in the absolute number
f telencephalic stem cells between E8.5 and E14.5–15.5,
ut recent estimates of the numbers of stem cells in the
dult forebrain subependyma (Morshead et al., 1998) sug-
Copyright © 1999 by Academic Press. All rightgest that the stem cell population may not substantially
increase from later embryogenesis to adulthood.
Neural Stem Cell Proliferation Is Differentially
Sensitive to EGF, FGF2, and Separate Cell
Nonautonomous Effects
Neural stem cell proliferation also may be secondarily
modulated via cell–cell communication in response to a
primary mitogenic signal. The present results reveal that
growth factor concentration regulates the proliferation of
neural stem cells in a cell density-dependent manner. The
secretion of diffusable factors by responsive cells may
subserve such cell nonautonomous effects. Furthermore,
the concentration of the factor(s) will be greater when many
secreting cells are in close proximity than when only a few
dispersed cells are present. Therefore, the density of cells
plated in a volume of media is critical for enabling endog-
enous secreted factor(s) to influence neural stem cell pro-
liferation in our serum-free conditions. Others (Hulspas et
al., 1997) have demonstrated that the proliferation of neural
stem cells is density-dependent even at cell densities rang-
ing from 50 to 200 cells/ml. Furthermore, Hulspas et al.
(1997) showed that by mixing cells of a ROSA26 genetic
background with cells of a Balb/c genetic background that
virtually all of their stem cell colonies at such high cell
densities were clonal (i.e., did not contain a mixture of cells
with both genotypes). This was also true in our results with
ROSA26-FGFR1(2/2) and ROSA26-FGFR1(1/2) diploid chime-
as. When striatal GZ tissue, containing a mixture of ROSA
nd CD1 cells, was dissociated and cultured at low cell
ensity in vitro, the neurospheres that were generated
ere either composed of entirely b-gal1 (blue) cells or
ntirely CD1 (white) cells and no mixed clones were ob-
erved.
In the present study, we demonstrated that there is a
acilitative effect of increased density on the proliferation of
oth FGF- and EGF-responsive neural stem cell subpopula-
ions, but which may have a greater influence EGF-
esponsive stem cell proliferation. We have also shown that
eural stem cell proliferation (at both high and low cell
ensities and in the presence of optimal concentrations of
xogenous EGF or FGF2) is independent of the endogenous
ecretion of FGF2 or EGF by neural precursors in response
o the primary exogenous mitogenic signal. Therefore, the
ature of the observed cell nonautonomous effects remains
o be determined. Proliferation of neuroepithelial cells has
een shown to depend on the production of IGF-1, acting
tself as a survival factor (Drago et al., 1991). Cellular
nteractions mediated by secreted factors also may regulate
eceptor levels. For example, KGF (FGF7) is a potent inducer
f TGFa in keratinocytes and causes activation and down
modulation of the EGFR (Dlugosz et al., 1994), influencing
keratinocyte responsiveness indirectly by activating an
EGFR-mediated signal for proliferation. Thus, mitogenic
signals from other members of the FGF growth factor
family or the upregulation of survival factors, such as IGF-1,
s of reproduction in any form reserved.
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185Growth Factor-Dependent Neural Stem Cell Proliferationmay mediate the cell nonautonomous effects which poten-
tiate the FGF- and EGF-responsive neural stem cell prolif-
eration. The source of these factors also remains undeter-
mined. Even at high cell densities, pure populations of
oligodendrocyte precursors do not divide in the absence of
exogenous growth factors, suggesting that mitogenic sig-
nals for these precursors originate from cell types other
than the precursors themselves (Barres et al., 1992). In the
present in vitro assay, primary cultured neural stem cells
are part of a heterogeneous population of GZ cells, includ-
ing postmitotic progenitors. Therefore, it will be of interest
to determine if the cell density-dependent proliferation is
mediated by stem cell interactions exclusively, by
progenitor/postmitotic cells, or by a mixture of all of these
cell types.
The Different Neural Stem Cells Maintain
Multipotentiality Irrespective of Growth Factor
Conditions
The independent EGF- and FGF-responsive neural stem
cells isolated here both demonstrate multilineage potential.
Consistent with previous results on expanding E10 cortical
precursors (Qian et al., 1997), the proportion of O41 oligo-
dendroglial progeny increases, with both increasing FGF2
and EGF concentrations in the present study. However, two
of the present results are notably different from these
previous findings. First, the proportion of GFAP1 astrocytes
as similar in all growth factor conditions assayed (Table
). Qian et al. (1997) reported that the glial cells generated
n cortical stem cell clones were predominantly of the
ligodendrocyte lineage (98%), and that only in the pres-
nce of astrocyte-meningeal cell-conditioned media (plus
GF2) would the percentage of glial-containing clones that
ontain astrocytes increase substantially. The present re-
ults demonstrate that neural stem cells isolated from the
triatal GZ generate all three major neural cell types. One
ossible explanation for these differences is that there are
emporal (E10 vs E14.5) and spatial (cortical GZ vs striatal
Z) restrictions on the competence of stem cells to gener-
te neurons and glia in response to growth factor concen-
ration. Second, the proportion of MAP21 neurons de-
creased with decreasing concentration of both FGF2 and
EGF (Table 1). This result stands in contrast to the previous
finding that the percentage of b-tubulin III1 neurons present
in cortical stem cell clones increased to .90% in low
concentrations of FGF2 (Qian et al., 1997). Low FGF2
concentrations may delay neuronal differentiation of pro-
genitors rather than act on the stem cells directly. Thus, the
increase in b-tubulin III1 cells (Qian et al., 1997) may
represent a selective increase in the proportion of immature
neurons which then results in a corresponding decrease in
the proportion of more differentiated (MAP21) neurons
(Table 1). It is possible that the instructive capacity of EGF
and FGF2 may only be revealed when a very small number
of cells (i.e., small number of cells/clone) are present in a
well, as was the case in the study reported by Qian et al.
Copyright © 1999 by Academic Press. All right1997). Perhaps the same cell nonautonomous effects that
acilitate neural stem cell proliferation from a primary
ulture are also present within neurospheres (i.e., a rela-
ively greater number of cells/clone) to ensure the multipo-
entiality of the stem cell by maintaining relatively similar
roportions of various differentiated progeny, even under
arious growth factor conditions. The presence of EGFR
nd FGFR1 on all neural stem cell-derived cells within a
eurosphere indicates that the degree to which neuronal
nd glial fate may be altered also depends on the ability of
GF or FGF2 to act in a inductive manner on the progeny of
eural stem cells (rather than on the stem cells themselves)
o promote progenitor cell survival, differentiation, or pro-
iferation. Although it remains formally possible that EGF
nd FGF2 can differentially instruct stem cells to generate
eurons and glia (Johe et al., 1996), the cells isolated by
ian et al. (1997) may be a later precursor in the stem cell
ineage, that may or may not be multipotential, compared
o the stem cell isolated in the neurosphere assay which is
ultipotential and self-renewing. Indeed, we would suggest
hat the true neural stem cells (EGF- or FGF-responsive)
lways retain their undifferentiated multipotential state
hroughout life and that inductive environmental signals
nfluence the differentiation of the progeny of the stem cells
although not the stem cells themselves). For example,
DNF (Ahmed et al., 1995) and IGF-1 (Arsenijevic and
eiss, 1998) have been shown to enhance the differentia-
ion of neurons from EGF-derived neurospheres, while bone
orphogenetic proteins (BMPs) (Gross et al., 1996) promote
strocyte differentiation from EGF-derived neurospheres.
The presence of different classes of stem cells during
evelopment raises the possibility that the early specifica-
ion of telencephalic compartments may be partly due to
he establishment of different stem cell populations. Al-
hough in the present study both EGF- and FGF-responsive
tem cells retain their multilineage potential in defined
erum-free conditions, it is possible that there are unique
ntrinsic components in each of the separate stem cell
ineages. The interaction between such distinct intracellu-
ar components and selective exogenous factors (e.g.,
DNF, IGF-1, BMPs) may act to regulate the production of
pecific types or numbers of neuronal and glial progeny in a
emporally and spatially dependent manner.
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